Street Research

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Get Free Trial
Send Info
Recommendations
BTIG sees Binance news as 'net positive' for Coinbase » 14:58
05/13/21
05/13
14:58
05/13/21
14:58
COIN

Coinbase

$260.36 /

-23.24 (-8.19%)

, BITCOIN

Bitcoin

/

+

BTIG analyst Mark Palmer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
COIN Coinbase
$260.36 /

-23.24 (-8.19%)

05/12/21
Cathie Wood's ARK Investment discloses 47.2K shares of Coinbase bought today
05/11/21
Coinbase says 'currently investigating' issue with EOS withdrawals
04/30/21
IntercontinentalExchange sells Coinbase stake for $1.2B
04/30/21
Coinbase acquires London-based crypto analytics platform Skew
BITCOIN Bitcoin
/

+

13:41 Today
Bitcoin price down 14% to $47,542 after Musk says Tesla no longer accepting
05/12/21
Bitcoin price slips after Tesla suspends purchases with currency
05/12/21
Tesla suspends vehicle purchases using Bitcoin, says Musk
05/12/21
Ackman says wouldn't invest firm's assets in Bitcoin
COIN Coinbase
$260.36 /

-23.24 (-8.19%)

09:53 Today
Fly Intel: Top five analyst initiations
06:02 Today Compass Point
Coinbase initiated with a Neutral at Compass Point
05/10/21 Oppenheimer
Oppenheimer starts Coinbase at Outperform with $434 price target
05/10/21 Oppenheimer
Coinbase initiated with an Outperform at Oppenheimer
BITCOIN Bitcoin
/

+

04/27/21 Roth Capital
Regulatory credits, bitcoin fuel Tesla Q1 headline beat, says Roth Capital
04/15/21 Morgan Stanley
WisdomTree Bitcoin ETP cross-listing could speed up growth, says Morgan Stanley
COIN Coinbase
$260.36 /

-23.24 (-8.19%)

13:14 Today
Notable companies reporting after market close
05/05/21
Fly Intel: What to watch in PayPal earnings report
04/06/21
Coinbase gives Q2, FY21 expenses guidance
04/06/21
Coinbase reports Q1 estimated total revenue of $1.8B
BITCOIN Bitcoin
/

+

05/05/21
Fly Intel: What to watch in PayPal earnings report
04/22/21
Fly Intel: What to watch in credit card space earnings reports
  • 14
    Apr
COIN Coinbase
$260.36 /

-23.24 (-8.19%)

04/17/21
Coinbase 'the best way' to play bitcoin boom, Barron's says
04/06/21
Coinbase's independent directors will have direct ties to company, WSJ reports
03/21/21
Coinbase direct listing pushed back to April, Bloomberg reports
02/19/21
'Heard on the Street' highlights PayPal, Square among crypto-exposure names
BITCOIN Bitcoin
/

+

09:23 Today
Steve Cohen's Point72 poised to enter cryptocurrency market, The Block says
05/07/21
Goldman Sachs opens up trading with new Bitcoin derivatives, Bloomberg says
05/04/21
JPMorgan CEO still not a bitcoin supporter, CNBC reports
04/17/21
Coinbase 'the best way' to play bitcoin boom, Barron's says
COIN Coinbase
$260.36 /

-23.24 (-8.19%)

10:00 Today
Microsoft initiation, Lowe's upgrade among today's top calls on Wall Street
05/12/21
Fly Intel: After-Hours Movers
05/11/21
Shopify, Nike upgrades among today's top calls on Wall Street
05/07/21
The Intersection: Crypto and Wall Street This Week
BITCOIN Bitcoin
/

+

12:25 Today
Fly Intel: Wall Street's top stories at midday
05/07/21
The Intersection: Crypto and Wall Street This Week
04/30/21
The Intersection: Crypto and Wall Street This Week
04/26/21
Fly Intel: What to watch in Tesla earnings report
17:00 Today
Coinbase - COIN
COIN Coinbase
$260.36 /

-23.24 (-8.19%)

05/10/21
Coinbase call volume above normal and directionally bullish
04/30/21
Coinbase call volume above normal and directionally bullish
04/20/21
Coinbase options debut following a week of active spot trading
04/20/21
Four new option listings and one option delisting on April 20th
Upgrade
Crispr Therapeutics upgraded to Outperform from In Line at Evercore ISI » 14:14
05/13/21
05/13
14:14
05/13/21
14:14
CRSP

Crispr Therapeutics

$97.48 /

-3.345 (-3.32%)

Evercore ISI analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CRSP Crispr Therapeutics
$97.48 /

-3.345 (-3.32%)

05/12/21
Crispr, Vertex to present new clinical data on CTX001 at EHA 2021
04/26/21
Crispr Therapeutics, Vertex granted PRIME designation for CTX001
04/20/21
Crispr Therapeutics, Vertex amend collaboration for CTX001
04/11/21
Crispr Therapeutics presents preclinical data on CD70 Knockout
CRSP Crispr Therapeutics
$97.48 /

-3.345 (-3.32%)

14:11 Today Evercore ISI
Evercore upgrades Crispr Therapeutics to Outperform ahead of 2021 data readouts
14:01 Today Evercore ISI
Crispr Therapeutics upgraded to Outperform from In Line at Evercore ISI
04/21/21 Jefferies
Jefferies upgrades Crispr Therapeutics to Buy after Vertex deal renegotiated
04/21/21 Barclays
Crispr Therapeutics price target raised to $160 from $140 at Barclays
CRSP Crispr Therapeutics
$97.48 /

-3.345 (-3.32%)

04/27/21
Crispr Therapeutics reports Q1 EPS ($1.51), consensus ($1.47)
02/16/21
Crispr Therapeutics reports Q4 EPS ($1.50), consensus ($1.27)
  • 01
    Jul
CRSP Crispr Therapeutics
$97.48 /

-3.345 (-3.32%)

04/20/21
Fly Intel: Wall Street's top stories for Tuesday
12/07/20
Fly Intel: Wall Street's top stories for Monday
12/07/20
Crispr rises following ASH update for genome editing cell therapy candidate
06/07/21
2021 ASCO Annual Virtual Meeting
CRSP Crispr Therapeutics
$97.48 /

-3.345 (-3.32%)

04/23/21
Crispr Therapeutics call volume above normal and directionally bullish
03/22/21
Crispr Therapeutics call volume above normal and directionally bullish
Recommendations
WildBrain price target raised to C$2.90 from C$2.80 at Canaccord » 14:00
05/13/21
05/13
14:00
05/13/21
14:00
WLDBF

WildBrain

$2.19 /

-0.3038 (-12.18%)

Canaccord analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WLDBF WildBrain
$2.19 /

-0.3038 (-12.18%)

02/11/21 Canaccord
WildBrain price target raised to C$2.80 from C$1.60 at Canaccord
02/11/21 BMO Capital
WildBrain price target raised to C$3 from C$2 at BMO Capital
02/11/21 RBC Capital
WildBrain price target raised to C$3 from C$2 at RBC Capital
02/11/21 National Bank
WildBrain price target raised to C$3 from C$1.80 at National Bank
Recommendations
Summit Industrial Income price target raised to C$16 from C$14 at Canaccord » 14:00
05/13/21
05/13
14:00
05/13/21
14:00
SMMCF

Summit Industrial Income REIT

$13.14 /

+0.128715 (+0.99%)

Canaccord analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SMMCF Summit Industrial Income REIT
$13.14 /

+0.128715 (+0.99%)

12:28 Today CIBC
Summit Industrial Income REIT price target raised to C$16.50 from C$15 at CIBC
12:00 Today National Bank
Summit Industrial Income price target raised to C$18 from C$17 at National Bank
11:50 Today Raymond James
Summit Industrial price target raised to C$17.50 from C$17 at Raymond James
11:27 Today Scotiabank
Summit Industrial price target raised to C$16.50 from C$15.50 at Scotiabank
Recommendations
Nuvista Energy price target raised to C$2.75 from C$2.25 at Canaccord » 13:59
05/13/21
05/13
13:59
05/13/21
13:59
NUVSF

Nuvista Energy

$2.16 /

+0.03 (+1.41%)

Canaccord analyst Anthony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NUVSF Nuvista Energy
$2.16 /

+0.03 (+1.41%)

12:06 Today Stifel
Nuvista Energy price target raised to C$3.75 from C$2.50 at Stifel
04/15/21 Scotiabank
Nuvista Energy price target raised to C$2.75 from C$2.20 at Scotiabank
04/15/21 National Bank
Nuvista Energy downgraded to Sector Perform from Outperform at National Bank
03/10/21 CIBC
Nuvista Energy price target raised to C$3.25 from C$2.50 at CIBC
Recommendations
Inovalis Real Estate price target lowered to C$10.50 from C$10.75 at Canaccord » 13:59
05/13/21
05/13
13:59
05/13/21
13:59
IVREF

Inovalis Real Estate

$8.10 /

-0.1572 (-1.90%)

Canaccord analyst Brendon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IVREF Inovalis Real Estate
$8.10 /

-0.1572 (-1.90%)

03/29/21 BMO Capital
Inovalis Real Estate price target raised to C$9.50 from C$9 at BMO Capital
03/26/21 Canaccord
Inovalis Real Estate price target raised to C$10.75 from C$9.50 at Canaccord
01/22/21 National Bank
Inovalis Real Estate price target raised to C$10 from C$9.50 at National Bank
11/18/20 Canaccord
Inovalis Real Estate price target raised to C$9.50 from C$9.25 at Canaccord
Recommendations
Green Thumb Industries price target raised to C$54 from C$52 at Canaccord » 13:58
05/13/21
05/13
13:58
05/13/21
13:58
GTBIF

Green Thumb Industries

$29.47 /

-0.67 (-2.22%)

Canaccord analyst Matt…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GTBIF Green Thumb Industries
$29.47 /

-0.67 (-2.22%)

07:56 Today
Green Thumb, COOKIES announce opening of COOKIES on Las Vegas Strip
05/03/21
Green Thumb Industries to acquire Dharma Pharmaceuticals, terms not disclosed
05/02/21
Fly Intel: Top five weekend stock stories
04/30/21
Green Thumb Industries announces $217M senior debt financing
GTBIF Green Thumb Industries
$29.47 /

-0.67 (-2.22%)

03/29/21 Alliance Global Partners
NY cannabis bill 'big win' for Acreage and Curaleaf, says Alliance Global
03/18/21 Craig-Hallum
Green Thumb Industries price target raised to $60 from $55 at Craig-Hallum
03/18/21 Alliance Global Partners
Green Thumb price target raised to C$55 from C$50 at Alliance Global Partners
03/18/21 Piper Sandler
Green Thumb Industries price target raised to $40 from $35 at Piper Sandler
GTBIF Green Thumb Industries
$29.47 /

-0.67 (-2.22%)

05/01/21
Legalized marijuana will be big win for U.S. pot stocks, Barron's says
03/31/21
Green Thumb part of pay-to-play investigation, Chicago Tribune reports
GTBIF Green Thumb Industries
$29.47 /

-0.67 (-2.22%)

05/06/21
Rising High: Tilray closes merger with Aphria, expects $81M of synergies
03/04/21
Rising High: Greenlane buys Eyce as Green Thumb partners with Cann
06/02/21
41st Annual Consumer Marketplace Virtual Conference
Recommendations
Drone Delivery Canada price target lowered to C$1.75 from C$2 at Canaccord » 13:57
05/13/21
05/13
13:57
05/13/21
13:57
TAKOF

Drone Delivery Canada

$1.00 /

-0.0247 (-2.42%)

Canaccord analyst Doug…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TAKOF Drone Delivery Canada
$1.00 /

-0.0247 (-2.42%)

03/01/21 Stifel
Drone Delivery Canada downgraded to Hold from Buy at Stifel
02/05/21 Canaccord
Drone Delivery Canada price target raised to C$2 from C$1.30 at Canaccord
Recommendations
DREAM Unlimited price target raised to C$32.50 from C$27 at Canaccord » 13:57
05/13/21
05/13
13:57
05/13/21
13:57
DRUNF

DREAM Unlimited

$19.33 /

+0.1908 (+1.00%)

Canaccord analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DRUNF DREAM Unlimited
$19.33 /

+0.1908 (+1.00%)

12:25 Today CIBC
DREAM Unlimited price target raised to C$29 from C$27 at CIBC
05/12/21 TD Securities
DREAM Unlimited price target raised to C$30 from C$28 at TD Securities
02/25/21 Canaccord
DREAM Unlimited price target raised to C$27 from C$26 at Canaccord
02/25/21 CIBC
DREAM Unlimited price target raised to C$27 from C$24 at CIBC
Recommendations
Dye & Durham price target raised to C$65 from C$60 at Canaccord » 13:56
05/13/21
05/13
13:56
05/13/21
13:56
DYNDF

Dye & Durham

$31.66 /

+ (+0.00%)

Canaccord analyst Robert…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DYNDF Dye & Durham
$31.66 /

+ (+0.00%)

12:22 Today BMO Capital
Dye & Durham price target lowered to C$53 from C$55 at BMO Capital
11:46 Today Raymond James
Dye & Durham price target raised to C$63 from C$58 at Raymond James
11:12 Today Scotiabank
Dye & Durham price target raised to C$58 from C$57 at Scotiabank
05/03/21 CIBC
Dye & Durham initiated with a Neutral at CIBC

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.